sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_2841> biolink:category biolink:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_2841> ;
    rdf:predicate biolink:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB01136> ;
    a rdf:Statement ;
    rdfs:label "\"Carvedilol tablets are contraindicated in the following conditions:    Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of carvedilol tablets. Second- or third-degree AV block Sick sinus syndrome Severe bradycardia (unless a permanent pacemaker is in place) Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating carvedilol tablets. Patients with severe hepatic impairment Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol.   Bronchial asthma or related bronchospastic conditions ( )  4 Second- or third-degree AV block ( )  4 Sick sinus syndrome ( )  4 Severe bradycardia (unless permanent pacemaker in place) ( )  4 Patients in cardiogenic shock or decompensated heart failure requiring the use of IV inotropic therapy. ( )  4 Severe hepatic impairment ( , )  2.4 4 History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol. ( )  4\"" ;
    biolink:provided_by <https://w3id.org/um/NeuroDKG> ;
    biolink:relation schema:MedicalContraindication .
  <https://identifiers.org/drugbank:DB01136> biolink:category biolink:Drug .
}